Pfizer may take over King Pharmaceuticals, analysts say
Pfizer may acquire King Pharmaceuticals, maker of the blood-pressure drug Altace, some analysts said. Representatives for both companies declined to comment on the reported buyout.
Bloomberg | 08/05
This story published in BIO SmartBrief on 08/06/2008
More from SmartBrief:
Judge removes 3 restraining orders against ZymoGenetics
Monday, November 9, 2009
3 restraining orders placed on ZymoGenetics regarding Recothrom
Thursday, November 5, 2009
Scientists find connection between MS, high blood pressure
Wednesday, August 19, 2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|